SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-058034
Filing Date
2020-12-22
Accepted
2020-12-22 16:01:19
Documents
13
Period of Report
2020-12-17
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fate-8k_20201217.htm   iXBRL 8-K 40491
2 EX-3.1 fate-ex31_6.htm EX-3.1 5204
  Complete submission text file 0001564590-20-058034.txt   180467

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fate-20201217.xsd EX-101.SCH 5808
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fate-20201217_lab.xml EX-101.LAB 20229
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fate-20201217_pre.xml EX-101.PRE 12108
6 EXTRACTED XBRL INSTANCE DOCUMENT fate-8k_20201217_htm.xml XML 3686
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36076 | Film No.: 201407979
SIC: 2836 Biological Products, (No Diagnostic Substances)